Contact FreedomWorks

111 K Street NE
Suite 600
Washington, DC 20002

  • Toll Free 1.888.564.6273
  • Local 202.783.3870

Regulatory Reform - May 2017

Regulatory Reform - May 2017

Regulatory Action Center
A Project of FreedomWorks Foundation
WATCH NOWAmerica Remasked, The Cleveland Indians Renamed, & Rep. Chip Roy's Rowdy SpeechWatch Here

All the Latest

    Everything
  • Blog
  • Events
  • Press
  • Key Votes
  • Podcasts
  • Videos
  • Tweets
  • Photos

About

""
""
https://fw-d7-freedomworks-org.s3.amazonaws.com/styles/thumbnail/s3/field/image/ORielly.jpg?itok=XmScB51K
Blog

Sen. Jim Inhofe's Unhinged Crusade Against the FCC Takes a Dark Turn

Back in May, a group of bipartisan lawmakers used a variety of misleading talking points to attack the Federal Communications Commission (FCC). The group, led by Senate Armed Services Committee Chairman Jim Inhofe (R-Okla.), took issue with the FCC’s order freeing up spectrum for use to develop next generation technology. The concerns revolved around objections by the Department of Defense (DoD) about whether this new allocation of spectrum would impact their ability to track aircraft.

07/29/2020
""
""
https://fw-d7-freedomworks-org.s3.amazonaws.com/styles/thumbnail/s3/field/image/myths-busted.jpg?itok=Va2mDnOB
Blog

Fact Checking on Trump's Price Control Executive Order

On Friday, President Trump issued three executive orders (and threatened a fourth) outlining sweeping changes he planned to make regarding prescription drug prices in the United States. One order seeks to make federal grants to federally qualified health centers contingent upon discounted insulin prices. A second would allow personal and wholesale importation of prescription drugs from overseas. The third implements rebate reform for pharmacy benefits managers (PBMs).

07/28/2020
""
""
https://fw-d7-freedomworks-org.s3.amazonaws.com/styles/thumbnail/s3/field/image/RxPrice.jpeg?itok=jITjnh2n
Blog

Price Controls Aren't Solutions

Prices for prescription drugs in the U.S. are far too high. There is no denying this sad reality. According to an analysis done by the House Ways and Means Committee, the U.S. pays roughly four times as much as 11 similar nations for prescription drugs. For millions of patients, families, and caregivers, this is unacceptable. Policymakers are right when they say something needs to be done.

07/24/2020
""
""
https://fw-d7-freedomworks-org.s3.amazonaws.com/styles/thumbnail/s3/field/image/precriptiondrugs.jpg?itok=cOE919na
Op-ed Placement

With Price Controls, A 'Most Favored Nations' Proposal Puts America Last

Last year, some supposedly conservative lawmakers - namely those within the Department of Health and Human Services (HHS) - shocked their admirers by endorsing price controls on prescription drugs. This proposal, known as the international price index (IPI), would tie the prices of Medicare drugs in the U.S. to prices in a select set of foreign nations. Many of those foreign nations already apply their own price controls.

07/20/2020
""
""
https://fw-d7-freedomworks-org.s3.amazonaws.com/styles/thumbnail/s3/field/image/RACReview-Thumbnail_0_0.png?itok=hy28BVLC
Blog

Regulatory Action Center Review - July 16, 2020

LIVE @WhiteHouse: Federal Affairs @DanielSavickas Assesses President @realDonaldTrump's Successful Deregulatory Agenda Before the Election! #ampFW https://t.co/1wJIGkdO4z https://t.co/QwzOQufZt9 pic.twitter.com/oGY617rzXE

07/16/2020
""
""
https://fw-d7-freedomworks-org.s3.amazonaws.com/styles/thumbnail/s3/field/image/oped1.jpg?itok=EhOp5H88
Blog

Trump Administration Clarifies Rules on Frivolous Asylum Claims

FreedomWorks Foundation’s Regulatory Action Center (RAC) is driving comments in support of the Trump administration’s proposed changes bolstering restrictions on frivolous asylum claims. You can make your voice heard HERE.

07/09/2020
""
""
https://fw-d7-freedomworks-org.s3.amazonaws.com/styles/thumbnail/s3/field/image/IQOS.jpg?itok=wf6SRBiJ
Press Release

FreedomWorks Foundation Statement in Response to FDA Approving the Marketing of IQOS as Modified Risk Tobacco Product

WASHINGTON, D.C. -- In response to the Food and Drug Administration (FDA) authorizing Philip Morris to market its IQOS heating system as a modified risk tobacco product (MRTP), Dan Savickas, FreedomWorks Foundation’s Regulatory Policy Manager commented:

07/07/2020
""
""
https://fw-d7-freedomworks-org.s3.amazonaws.com/styles/thumbnail/s3/field/image/RACReview-Thumbnail_0.png?itok=35oYpcPt
Blog

Regulatory Action Center Review - July 1, 2020

07/01/2020
""
""
https://fw-d7-freedomworks-org.s3.amazonaws.com/styles/thumbnail/s3/field/image/paper.jpg?itok=kjAEaBUW
Blog

The Most Important Federal Agency You've Never Heard Of

The Executive Branch of our federal government is massive; so massive that no one knows exactly how many federal agencies there are. Nevertheless, the Executive Office of the President (EOP) must efficiently manage the massive amount of regulatory actions that come from these innumerable agencies. Tasked with being the primary check-point for regulations before they are implemented, the Office of Information and Regulatory Affairs, otherwise known as OIRA, is the most important federal agency that you’ve probably never heard of.

06/30/2020
""
""
https://fw-d7-freedomworks-org.s3.amazonaws.com/styles/thumbnail/s3/field/image/Enviro.jpg?itok=7ayPEqir
Issue Analysis

Green Thumbs Down

FreedomWorks Foundation's Regulatory Action Center (RAC) has published an issue brief on the environmental regulations the Trump administration has rolled back. You can read the paper excerpted below or in its entirety in the attachment at the bottom of this post or HERE.

06/23/2020

Pages